Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;120(7):1953-1960.
doi: 10.1002/bit.28414. Epub 2023 May 26.

A new T-antigen negative HEK293 cell line with improved AAV productivity

Affiliations

A new T-antigen negative HEK293 cell line with improved AAV productivity

Coralie Croissant et al. Biotechnol Bioeng. 2023 Jul.

Abstract

Viral vectors for gene therapy, such as recombinant adeno-associated viruses, are produced in human embryonic kidney (HEK) 293 cells. However, the presence of the SV40 T-antigen-encoding CDS SV40GP6 and SV40GP7 in the HEK293T genome raises safety issues when these cells are used in manufacturing for clinical purposes. We developed a new T-antigen-negative HEK cell line from ExcellGene's proprietary HEKExpress,® using the CRISPR-Cas9 strategy. We obtained a high number of clonally-derived cell populations and all of them were demonstrated T-antigen negative. Stability study and AAV production evaluation showed that the deletion of the T-antigen-encoding locus did not impact neither cell growth nor viability nor productivity. The resulting CMC-compliant cell line, named HEKzeroT,® is able to produce high AAV titers, from small to large scale.

Keywords: AAV; HEK293; T-antigen; gene therapy; manufacturing.

PubMed Disclaimer

References

REFERENCES

    1. Bae, D. H., Marino, M., Iaffaldano, B., Fenstermaker, S., Afione, S., Argaw, T., McCright, J., Kwilas, A., Chiorini, J. A., Timmons, A. E., & Reiser, J. (2020). Design and testing of vector-producing HEK293T cells bearing a genomic deletion of the SV40 T antigen coding region. Molecular Therapy-Methods & Clinical Development, 18, 631-638. https://doi.org/10.1016/j.omtm.2020.07.006
    1. Blessing, D., Vachey, G., Pythoud, C., Rey, M., Padrun, V., Wurm, F. M., Schneider, B. L., & Déglon, N. (2019). Scalable production of AAV vectors in orbitally shaken HEK293 cells. Molecular Therapy-Methods & Clinical Development, 13, 14-26. https://doi.org/10.1016/j.omtm.2018.11.004
    1. Chahal, P. S., Schulze, E., Tran, R., Montes, J., & Kamen, A. A. (2014). Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery. Journal of Virological Methods, 196, 163-173. https://doi.org/10.1016/j.jviromet.2013.10.038
    1. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., & Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Molecular and Cellular Biology, 7(1), 379-387. https://doi.org/10.1128/mcb.7.1.379-387.1987
    1. Eddy, B. E., Borman, G. S., Grubbs, G. E., & Young, R. D. (1962). Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology, 17, 65-75. https://doi.org/10.1016/0042-6822(62)90082-x

Substances

LinkOut - more resources